The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 2,826 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 526 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 2,487 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 5,555 | 435,000 | SH | SOLE | 435,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 5,220 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 15,483 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 14,075 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 18,783 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 9,810 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 4,520 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,693 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 13,386 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 6,615 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 1,001 | 3,750 | SH | SOLE | 3,750 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 4,283 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 8,952 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 11,640 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 1,672 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 14,196 | 700,000 | SH | Call | SOLE | 700,000 | 0 | 0 | |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 4,642 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 2,792 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 1,100 | 61,300 | SH | Call | SOLE | 61,300 | 0 | 0 | |
IVERIC BIO INC | COM | 46583P102 | 8,319 | 463,700 | SH | SOLE | 463,700 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 6,748 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 4,520 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 1,625 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 12,222 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 2,328 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 2,165 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 18,219 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 5,026 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
RELMADA THERAPEUTICS INC | COM | 75955J402 | 18,510 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
RELMADA THERAPEUTICS INC | COM | 75955J402 | 15,734 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 10,530 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 1,593 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 12,159 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 6,842 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
SPDR SER TR | S&P BIOTECH | 78464A870 | 39,660 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 4,806 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 2,054 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 2,096 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 5,240 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
VAXCYTE INC | COM | 92243G108 | 8,640 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 10,973 | 535,000 | SH | SOLE | 535,000 | 0 | 0 |